NCT03449901: ADI-PEG 20 in Combination With Gemcitabine and Docetaxel for the Treatment of Soft Tissue Sarcoma, Osteosarcoma, Ewing's Sarcoma, and Small Cell Lung Cancer |
|
|
| Completed | 2 | 98 | US | pegylated arginine deiminase, ADI-PEG 20, Gemcitabine, Gemzar, Docetaxel, Taxotere, Tumor biopsy, Research blood draw | Washington University School of Medicine, National Institutes of Health (NIH), National Cancer Institute (NCI) | Soft Tissue Sarcoma | 07/22 | 07/22 | | |
NCT05813327: Neoadjuvant ADI-PEG 20 + Ifosfamide + Radiotherapy in Soft Tissue Sarcoma |
|
|
| Recruiting | 1/2 | 35 | US | ADI PEG20, PEGylated arginine deiminase, Ifosfamide, ifex, Radiotherapy, Mesna, sodium 2-mercaptoethane sulfonate | Washington University School of Medicine, Polaris Group | Soft Tissue Sarcoma, Sts, Sarcoma,Soft Tissue | 01/26 | 01/28 | | |
